Kirane, A. (2012). "Apricoxib, a Novel Inhibitor of COX-2, Markedly Improves Standard Therapy Response in Molecularly Defined Models of Pancreatic Cancer". Clinical Cancer Research. Quyển 18 số 18. tr. 5031–5042. doi:10.1158/1078-0432.CCR-12-0453. PMC3777527. PMID22829202.
Kirane, A. (2012). "Apricoxib, a Novel Inhibitor of COX-2, Markedly Improves Standard Therapy Response in Molecularly Defined Models of Pancreatic Cancer". Clinical Cancer Research. Quyển 18 số 18. tr. 5031–5042. doi:10.1158/1078-0432.CCR-12-0453. PMC3777527. PMID22829202.
pubmed.ncbi.nlm.nih.gov
Kirane, A. (2012). "Apricoxib, a Novel Inhibitor of COX-2, Markedly Improves Standard Therapy Response in Molecularly Defined Models of Pancreatic Cancer". Clinical Cancer Research. Quyển 18 số 18. tr. 5031–5042. doi:10.1158/1078-0432.CCR-12-0453. PMC3777527. PMID22829202.